Systemic Lupus Erythematosus: Limited Therapeutic Advances and Treatment Challenges
Systemic lupus erythematosus (SLE) patients may soon gain a new weapon in their fight against this relentless autoimmune disease. Enpatoran, a novel selective sphingosine-1-phosphate receptor 1 (S1P1) modulator, has shown ... Read More